This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The investigational oral, selective NaV1.8 pain signal inhibitor from Vertex Pharmaceuticals demonstrated a favorable benefit/risk profile in 3 phase 3 trials.
Anisha Patel, PharmD, a pharmacist turned podcast host, shares insights on leveraging all the opportunities pharmacy has to offer to build a diverse and rewarding career.
Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by the Lancet Commission. These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.
CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne donuts, plant-based frozen yogurt and buñuelos, white cheddar cheese puffs, chocolatey cookie dippers, egg-free Spanish cheesecake, plant-based chorizo-style empanadas … I was at the annual gathering of food technologists this month to learn about, well, food technology, and I had found myself in the exhibit hall, testing how much I could eat before needi
Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.
A trust controlled by 23andMe co-founder Anne Wojcicki has formally filed to take the genetic testing firm private, offering to purchase all shares of the firm for 40 cents per share, the current stock price. The deal, which Wojcicki had previously telegraphed, was made public in a filing with the Securities and Exchange Commission on Wednesday; the proposal was made to a special committee of 23andMe’s board on Monday.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage (MA) space. | Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage space.
The Biden administration isn’t doing enough to ensure people living in recovery housing have access to gold-standard addiction medications like methadone and buprenorphine , according to a coalition of health care, harm reduction, and addiction recovery groups. The discrimination that people often face when seeking treatment using methadone or buprenorphine, the groups say, is especially pronounced within recovery housing facilities, which typically offer lodging coupled with counse
In its first quarter with new CEO Chuck Divita, national telehealth provider Teladoc Health posted a net loss of $838 million in Q2 that included a nearly $800 million impairment charge a | Teladoc said on its earnings call on Wednesday that challenges with BetterHelp and increasing advertising costs led its revenue to decline in Q2.
The BIOSECURE Act , now rolling through Congress, aims to protect the DNA data of Americans from companies with perceived national security risks. That is a noble goal. But the legislation’s misguided approach would single out a small number of companies, including the California-based company I founded in 2005, Complete Genomics , despite the fact that we have no access to such data.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
There are 75,000 homeless people in Los Angeles County, a county that is the size of Delaware and Rhode Island combined and has a population that is larger than 40 states. | L.A. Care Health Plan is sending social workers to temporary housing sites in Los Angeles County to find more permanent housing solutions.
In my third week as a medical intern, I learned a vital lesson about the realities of everyday medicine that textbooks and professors hadn’t taught me: how profoundly the financial cost of care affects patients. I was caring for a man admitted to the hospital with uncontrolled atrial fibrillation, an irregular and often rapid heartbeat. After much deliberation, I prescribed a new anticoagulant to prevent the formation of blood clots in his heart, instructed him to continue using his curre
Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more workers at the site. | Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more at the site, according to a state Worker Adjustment and Retraining Notification.
Good morning. We have a new investigation out today about how Mount Sinai in New York mounted an aggressive campaign to stifle debate over its controversial brain research. Check it out here. And let’s get into the biotech news.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Wells Fargo is the most recent corporation to get sued, as alleged by former employees, for inadequately overseeing the price workers were forced to pay for prescription drug prices. | Wells Fargo was named as a defendant in a new lawsuit for not protecting its workers from extreme prescription drug prices inflicted by Cigna's PBM, Express Scripts.
Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Frontiers Health 2024 is a platform connecting innovators and changemakers in the life sciences industry to cultivate positive changes in health systems. Discover the latest trends and insights in healthcare innovation.
On the heels of game-changing trial results presented at la | On the heels of game-changing trial results presented at last year's ASH meeting, J&J is introducing what it calls a "foundational frontline therapy" in multiple myeloma and at the same time expanding its already impressive presence in the field.
Vertex has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year
Bicycle Health, a virtual provider of opioid use disorder (OUD) treatment, is launching a program for teens in the state of Maine. | The company says this is the first program of its kind in the country. Patients 16 and 17 years of age will be eligible for medications for opioid use disorder via telehealth under the model. Bicycle decided to offer it in the state after hearing about a need directly from one of its payer partners.
Teva and its long-term investors have been through much disappointment over the last decade, but 2024 is bringing optim | Teva has boosted its revenue and profit outlook for the year after reporting a strong quarter for its generics business. The company's key growth driver Austedo contributed to the performance, as well.
Ensuring equitable access to medications remains a fundamental commitment for many pharmaceutical companies to their customers, patients, and stakeholders. However, there has been a discernible shift recently in the timing of access discussions.
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Surprisingly, a story by my colleagues Nick Florko and Sarah Owermohle about how Grindr hired a Washington lobbyist is NOT the first time the, uh, “social networking app” (their words!) has appeared in STAT reporting. A quick Google search tells me that the word first appeared in an early episode of The Readout LOUD.
The end of an era is nearing for Lundbeck. After a 17-year collaboration with Takeda on depression drug Trintellix, the Danish drugmaker is passing over its U.S. rights to its partner. | Lundbeck will collect only royalties on Takeda's U.S. sales of the partners' depression med as it reallocates resources to other growth drivers such as antipsychotic Rexulti.
The presence of glutamic acid decarboxylase antibodies in intravenous immunoglobulin can lead to a misdiagnosis of type 1 diabetes mellitus if a false-positive result is garnered.
The whole respiratory syncytial virus (RSV) vaccine field took a beating when the Centers for Disease Control and Prevention’s (CDC's) immunization committee doled out a limited recommendation last | The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last month. And it’s showing in GSK’s forecast for 2024, just as the company’s Shingrix disappointed.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content